[Remote] Sr. Director Product Management at Clairo

United States

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Bachelor’s degree in business, Engineering, Life Sciences, or related field required; MBA or advanced degree preferred
10–15 years of progressive experience in product management, healthcare technology, or clinical trial solutions
Deep knowledge of clinical trials and proven experience working with cardiac and respiratory medical devices
Demonstrated success leading global product teams in regulated environments (GxP, MDR, FDA 510(k), 21 CFR Part 11)
Strong business acumen with direct experience managing product P&L, growth targets, and lifecycle planning
Proven ability to collaborate cross-functionally and communicate product vision to technical and non-technical audiences

Responsibilities

Define and lead a market-driven product strategy aligned with Clario’s clinical technology goals
Drive multi-year roadmaps that prioritize innovation, regulatory compliance, and global scalability
Oversee the full product lifecycle for cardiac and respiratory device integrations in clinical trial workflows
Partner with Engineering, QA/RA, Operations, and Commercial teams to deliver compliant, high-performing solutions
Act as the strategic voice of the customer and market, translating insights into product opportunities
Lead and mentor a global team of Product Managers, instilling a high-performance, mission-driven culture
Monitor financial performance across the portfolio and support go-to-market planning, pricing, and ROI delivery

Skills

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free